October 29, 2020 — Accuray Incorporated, a pioneer in the robotic stereotactic radiosurgery (SRS) field announced a collaboration with Brainlab, a Munich, Germany based market leader in digital surgery and precision radiotherapy that will enhance and expand the Accuray CyberKnife treatment platform for the neuro-radiosurgery market. The two companies are partnering to provide the neuro-radiosurgery community with access to Brainlab Elements planning software, which will provide contouring capabilities optimized for neurosurgeons. The partners will further strive to leverage interoperability with Snke OS, the Brainlab health tech platform to ultimately improve the experience of those administering and receiving radiation treatments. This interoperability will also allow customers to add CyberKnife treatment data via Quentry, the Brainlab patient registry platform, and enable their participation in neuro-radiosurgery patient registries to help improve patient outcomes.
Snke OS is the platform from Brainlab that creates the linkage between data sources, driving comprehensive insights and analytics with the aim to improve health tech and best practices. The software delivers on the broader goal to create comprehensive digital patient models that are continuously updated and managed along the patient journey. Integration and aggregation of the patient models in the cloud-based version of Snke OS allows for systematic analysis and lays the foundation for digital clinical research. The platform is being designed to facilitate adaptive radiotherapy workflows by enabling rapid re-planning based on dynamic updates of the digital patient model.
The CyberKnife S7 System is a robotic, non-invasive radiation therapy device that offers a highly precise treatment for cancerous and benign tumors throughout the body, as well as functional neurologic/movement disorders. It is routinely used to treat conditions in the brain while minimizing dose to brain tissues involved in important functions such as hearing and vision. The CyberKnife System combines state-of-the-art robotic architecture with fully integrated image guidance and continual, delivery adaptation and motion synchronization, enabling the delivery of stereotactic radiosurgery with sub-millimeter precision and accuracy.
"The Accuray team is excited to partner with Brainlab, recognized leaders in treatment planning, surgical navigation and innovators in radiotherapy and radiosurgery solutions that advance patient care," said Joshua H. Levine, president and chief executive officer of Accuray. "This marks an important next step in the evolution of the CyberKnife platform by expanding the capabilities to align with the needs of the neurosurgical community. We believe our two companies bring powerful and complementary expertise that when combined, will raise the bar for what can be achieved in terms of efficiency, accuracy and precision, on behalf of neurosurgeons and their patients."
For more information: www.accuray.com
November 24, 2021 
